We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

Explore neuroscience breakthroughs reshaping treatments for Alzheimer’s, Parkinson’s, PTSD, and other brain disorders.

GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

New Jersey has long been one of the core hubs of the U.S. pharmaceutical industry, home to biotech companies such as Johnson & Johnson and Merck, as well as a dense network of research and development ...

Portugal’s biotech ecosystem may be small, but it is steadily on the rise. The life sciences industry in the country is particularly strong in the area of medical biotech and is supported by the ...

T cell engagers are antibodies engineered to redirect the immune system’s T cells to recognize and kill cancer cells. They are designed to bind to a target antigen expressed on a cancer cell and ...

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...